LitCovid-sample-Enju  

PMC:7253482 / 3074-3361 JSONTXT 15 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T469 4-7 CC denotes and
T470 8-14 NN denotes glycan
T471 15-24 NN denotes shielding
T472 25-28 VBZ denotes has
T473 29-33 VBN denotes been
T474 34-38 RB denotes well
T475 39-52 VBN denotes characterised
T476 53-59 IN denotes across
T477 60-65 JJ denotes other
T478 66-71 JJ denotes viral
T479 72-85 NNS denotes glycoproteins
T480 85-86 -COMMA- denotes ,
T481 87-91 JJ denotes such
T482 92-94 IN denotes as
T483 95-100 NN denotes HIV-1
T484 101-109 NN denotes envelope
T485 110-117 NN denotes protein
T486 118-119 -LRB- denotes (
T487 119-122 NN denotes Env
T488 122-123 -RRB- denotes )
T489 123-128 CD denotes 19–21
T490 128-129 -COMMA- denotes ,
T491 130-139 NN denotes influenza
T492 140-153 NN denotes hemagglutinin
T493 154-155 -LRB- denotes (
T494 155-157 NN denotes HA
T495 157-158 -RRB- denotes )
T496 158-163 CD denotes 22,23
T497 164-167 CC denotes and
T498 168-173 NNP denotes Lassa
T499 174-179 NN denotes virus
T500 180-192 NN denotes glycoprotein
T501 193-200 NN denotes complex
T502 201-202 -LRB- denotes (
T503 202-206 NN denotes LASV
T504 207-210 NN denotes GPC
T505 210-211 -RRB- denotes )
T506 211-216 CD denotes 24–26
T507 218-226 JJ denotes Previous
T508 227-235 NNS denotes analyses
T509 236-238 IN denotes of
T510 239-244 JJ denotes viral
T511 245-251 NN denotes glycan
T512 252-259 NNS denotes shields
T513 260-264 VBP denotes have
T514 265-273 VBN denotes revealed
T515 274-277 DT denotes the
T516 278-286 NN denotes presence
R466 T471 T469 arg2Of shielding,and
R467 T471 T470 arg1Of shielding,glycan
R469 T475 T472 arg2Of characterised,has
R471 T475 T473 arg2Of characterised,been
R472 T475 T474 arg1Of characterised,well
R474 T475 T476 arg1Of characterised,across
R475 T479 T476 arg2Of glycoproteins,across
R476 T479 T477 arg1Of glycoproteins,other
R477 T479 T478 arg1Of glycoproteins,viral
R478 T479 T480 arg1Of glycoproteins,","
R479 T482 T481 arg1Of as,such
R480 T479 T482 arg1Of glycoproteins,as
R481 T497 T482 arg2Of and,as
R482 T485 T483 arg1Of protein,HIV-1
R483 T485 T484 arg1Of protein,envelope
R484 T492 T485 arg1Of hemagglutinin,protein
R485 T485 T486 arg1Of protein,(
R486 T487 T486 arg2Of Env,(
R487 T488 T486 arg3Of ),(
R488 T485 T489 arg1Of protein,19–21
R489 T485 T490 arg1Of protein,","
R490 T491 T490 arg2Of influenza,","
R491 T492 T491 arg1Of hemagglutinin,influenza
R492 T492 T493 arg1Of hemagglutinin,(
R493 T494 T493 arg2Of HA,(
R494 T495 T493 arg3Of ),(
R495 T492 T496 arg1Of hemagglutinin,"22,23"
R496 T492 T497 arg1Of hemagglutinin,and
R497 T501 T497 arg2Of complex,and
R498 T501 T498 arg1Of complex,Lassa
R499 T501 T499 arg1Of complex,virus
R500 T501 T500 arg1Of complex,glycoprotein
R501 T501 T502 arg1Of complex,(
R502 T504 T502 arg2Of GPC,(
R503 T505 T502 arg3Of ),(
R504 T504 T503 arg1Of GPC,LASV
R505 T501 T506 arg1Of complex,24–26
R506 T508 T507 arg1Of analyses,Previous
R507 T508 T509 arg1Of analyses,of
R508 T512 T509 arg2Of shields,of
R509 T512 T510 arg1Of shields,viral
R510 T512 T511 arg1Of shields,glycan
R511 T508 T513 arg1Of analyses,have
R512 T514 T513 arg2Of revealed,have
R513 T508 T514 arg1Of analyses,revealed
R514 T516 T514 arg2Of presence,revealed
R515 T516 T515 arg1Of presence,the